Roche, Daiichi Sankyo Win U.S. Approval for Melanoma Drug

Roche Holding AG and Daiichi Sankyo Co. won U.S. clearance to sell a pill for melanoma that is among a new wave of medicines developed to fight the deadliest form of skin cancer.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.